TGFB1 and neoplasm: TAMs are involved in cancer progression inducing angiogenesis through VEGF secretion, immune evasion through immunosuppressive cytokines release (IL-10, TGFβ), and upregulating immune checkpoint expression such as PD-L1 on tumor cells [92–95].